HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2006, 08, 2 (pages: 5 - 22)

Say “Yes” to Methadone and Buprenorphine in Russian Federation

Maremmani I., Pacini M., Pani P. P., Parrino M.

Summary: The medical community has determined that narcotic addiction is a chronic and relapsing medical disorder, which is effectively treated with medications. The success rate of patients, who are treated with medications, such as methadone and buprenorphine, when combined with other needed treatment services, improves the health of the patient. Methadone and buprenorphine are the most exhaustively studied medications for the treatment of any disease. More than 40 years of research and clinical practice have repeatedly demonstrated its efficacy in millions of patients throughout the world. An objective observer might argue that it is irresponsible not to use such medications to treat narcotic addiction in an age of HIV infection, hepatitis-C and other developing co-morbidities

 

EUROPAD - European Opiate Addiction Treatment Association Rolex replica
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page